2021
DOI: 10.1016/j.drudis.2021.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Sodium ion channels as potential therapeutic targets for cancer metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 92 publications
0
7
0
Order By: Relevance
“…Based on a preliminary screening using RT-qPCR against two genes, SCN9A (NaV1.7) and SLC9A1 (NHE1), compound SV188 was selected for further evaluation, as it substantially lowered the expression of SLC9A1 (NHE1) and SCN9A (NaV1.7) compared to the corresponding controls (Figure 5C). Next, we tested SV188 against the NaV1.5, NaV1.6, and NaV1.7 channels that have been reported to be involved in cancer cells' migration and invasion [41,70]. The results showed that the treatment of SV188 at 5 µM for 48 h significantly decreased the mRNA expression of NaV1.7 and increased the mRNA expression of NaV1.5, with no significant effect on the mRNA expression of NaV1.6 (Figure 6).…”
Section: Identification Of Na V 17 Inhibitorsmentioning
confidence: 98%
See 3 more Smart Citations
“…Based on a preliminary screening using RT-qPCR against two genes, SCN9A (NaV1.7) and SLC9A1 (NHE1), compound SV188 was selected for further evaluation, as it substantially lowered the expression of SLC9A1 (NHE1) and SCN9A (NaV1.7) compared to the corresponding controls (Figure 5C). Next, we tested SV188 against the NaV1.5, NaV1.6, and NaV1.7 channels that have been reported to be involved in cancer cells' migration and invasion [41,70]. The results showed that the treatment of SV188 at 5 µM for 48 h significantly decreased the mRNA expression of NaV1.7 and increased the mRNA expression of NaV1.5, with no significant effect on the mRNA expression of NaV1.6 (Figure 6).…”
Section: Identification Of Na V 17 Inhibitorsmentioning
confidence: 98%
“…A few examples of such channels are Na V 1.5 in breast [40,51,52], colon [49], and ovarian cancers [64]; Na V 1.6 in cervical cancer [65]; and Na V 1.7 in prostate [66,67], gastric [34], lung [68], and endometrial cancers [69]. Over the past decade, VGSCs subtypes Na V 1.5, Na V 1.6, and Na V 1.7 have been the most-reported isoforms that are shown to influence migration and invasion [32,41,70]. We initially examined the mRNA expression levels of VGSCs isoforms Na V 1.5, Na V 1.6, and Na V 1.7 in NETs using pancreatic (BON), lung (H727), and thyroid (MZ-CRC-1 and TT) cells and observed that the aggressive MTC cells originated from lymph node metastasis; MZ-CRC-1 showed strong expression of channels Na V 1.5, Na V 1.6, and Na V 1.7.…”
Section: Vgsc Expression In Neuroendocrine Tumors (Nets)mentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to Ca 2+ signals, alterations in Na + hemostasis are also indicative of aggressive disease (reviewed in Horne et al , 2021 ). The Na + leak channel NALCN, first reported in hippocampal neurons (Lu et al , 2007 ), is a membrane multiprotein complex involved in cell excitability and trafficking whose genetic modifications are associated with neurological disorders (Rahrmann et al , 2022 ).…”
mentioning
confidence: 99%